The role of corticotropin-releasing factor in the median raphe nucleus in relapse to alcohol

Journal of Neuroscience

Volumn 22, Issue 18, 2002, Pages 7844-7849

  Le, A D ^a,b,c   Harding, S ^a   Juzytsch, W ^a   Fletcher, P J ^a,b,c   Shaham, Y ^d  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Alcohol; Corticotropin releasing factor; Reinstatement; Relapse; Serotonin; Stress

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; ALCOHOL; CORTICOTROPIN DERIVATIVE; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; FLUOXETINE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; WATER;

ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG RECEPTOR BINDING; HORMONE ACTION; MALE; MEDIAN RAPHE NUCLEUS; NONHUMAN; PRIORITY JOURNAL; RAT; RELAPSE; SHOCK;

EID: 0037107139     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.22-18-07844.2002     Document Type: Article

References (38)

1. Adell A, Myers RD (1995) Selective destruction of midbrain raphe nuclei by 5, 7-DHT: Is brain 5-HT involved in alcohol drinking in Sprague-Dawley rats? Brain Res 693:70-79.
2. Bittencourt JC, Sawchenko PE (2000) Do centrally administered neuropeptides access cognate receptors? An analysis in the central corticotropin-releasing factor system. J Neurosci 20:1142-1456.
3. Chalmers DT, Lovenberg TW, De Souza E (1995) Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: Comparison with CRF1 receptor mRNA expression. J Neurosci 15:6340-6350.
4. Erb S, Stewart J (1999) A role for the bed nucleus of the stria terminalis, but not the amygdala, in the effects of corticotropin-releasing factor on stress-induced reinstatement of cocaine seeking. J Neurosci 19:RC35(1-6).
5. Erb S, Shaham Y, Stewart J (1998) The role of corticotropin-releasing factor and corticosterone in stress- and cocaine-induced relapse to cocaine seeking in rats. J Neurosci 18:5529-5536.
6. Erb S, Salmaso N, Rodaros D, Stewart J (2001) A role for the CRF-containing pathway projecting from central nucleus of the amygdala to bed nucleus of the stria terminalis in the stress-induced reinstatement of cocaine seeking in rats. Psychopharmacology 158:360-365.
7. Fletcher PJ (1993) A comparison of the effects of dorsal and median raphe injections of 8-OH-DPAT in three operant tasks measuring response inhibition. Behav Brain Res 54:187-197.
8. Fletcher PJ (1995) Effects of combined or separate 5, 7-dihydroxytryptamine lesions of the dorsal and median raphe nuclei on responding maintained by a DRL 20s schedule of food reinforcement. Brain Res 675:45-54.
9. Fletcher PJ, Ming ZH, Higgins GA (1993) Conditioned place preference induced by microinjection of 8-OH-DPAT into the dorsal or median raphe nucleus. Psychopharmacology 113:31-36.
10. 1A receptor agonists. Eur J Pharmacol 193:351-356.
11. Highfield D, Clements A, Shalev U, McDonald RJ, Featherstone R, Stewart J, Shaham Y (2000) Involvement of the medial septum in stress-induced relapse to heroin seeking in rats. Eur J Neurosci 12:1705-1713.
12. Kirby LG, Rice KC, Valentino RJ (2000) Effects of corticotropin releasing factor on neuronal activity in the serotonergic dorsal raphe nucleus. Neuropsychopharmacology 22:148-162.
13. Le AD, Shaham Y (2002) Relapse to alcohol-taking behavior in rats. Pharmacol Ther 94:137-156.
14. Le AD, Quan B, Juzystch W, Fletcher PJ, Joharchi N, Shaham Y (1998) Reinstatement of alcohol-seeking by priming injections of alcohol and exposure to stress in rats. Psychopharmacology 135:169-174.
15. Le AD, Poulos CX, Harding S, Watchus W, Juzytsch W, Shaham Y (1999) Effects of naltrexone and fluoxetine on alcohol self-administration and reinstatement of alcohol seeking induced by priming injections of alcohol and exposure to stress in rats. Neuropsychopharmacology 21:435-444.
16. Le AD, Harding S, Watchus W, Juzytsch W, Shalev U, Shaham Y (2000) The role of corticotrophin-releasing factor in stress-induced relapse to alcohol-seeking behavior in rats. Psychopharmacology 150:317-324.
17. Linnoila MV, Virkkunen M (1992) Aggression, suicidality, and serotonin. J Clin Psychiatry [Suppl] 53:46-51.
18. Lowry CA (2002) Functional neuroanatomy of serolonergic systems: Implications for neuromodulation of the hypothalamic-pituitaryadrenal (HPA) axis. J Neuroendocrinol, in press.
19. Lowry CA, Rodda JE, Lightman SL, Ingram CD (2000) Corticotropin releasing factor increases in vitro firing rates of serotonergic neurons in the rat dorsal raphe nucleus: Evidence for activation of a topographically organized mesolimbocortical serotonergic system. J Neurosci 20:7728-7736.
20. Lu L, Ceng X, Huang M (2000) Corticotropin-releasing factor receptor type I mediates stress-induced relapse to opiate dependence in rats. NeuroReport 11:2373-2378.
21. Martin-Fardon R, Ciccocioppo R, Massi M, Weiss F (2000) Nociceptin prevents stress-induced ethanol- but not cocaine-seeking behavior in rats. NeuroReport 11:1939-1943.
22. Miller L (1991) Predicting relapse and recovery in alcoholism and addiction: Neuropsychology, personality, and cognitive style. J Subst Abuse Treat 8:277-291.
23. Mongeau R, Blier P, de Montigny C (1997) The serotonergic and noradrenergic systems of the hippocampus: Their interactions and the effects of antidepressant treatments. Brain Res Rev 23:145-195.
24. Paxinos G, Watson C (1998) The Rat Brain in Stereotaxic Coordinates, Ed 4. San Diego: Academic.
25. Piazza PV, Le Moal M (1998) The role of stress in drug self-administration. Trends Pharmacol Sci 19:67-74.
26. Poulos CX, Parker JL, Le AD (1996) Dexfenfluramine and 8-OHDPAT modulate impulsivity in a delay-of-reward paradigm: Implications for a correspondence with alcohol consumption. Behav Pharmacol 7:395-399.
27. Price ML, Lucki I (2001) Regulation of serotonin release in the lateral septum and striatum by corticotropin-releasing factor. J Neurosci 21:2833-2341.
28. Price ML, Curtis AL, Kirby LG, Valentino RJ, Lucki I (1998) Effects of corticotropin-releasing factor on brain serotonergic activity. Neuropsychopharmacology 18:492-502.
29. Shaham Y, Funk D, Erb S, Brown TJ, Walker CD, Stewart J (1997) Corticotropin-releasing factor, but not corticosterone, is involved in stress-induced relapse to heroin-seeking in rats. J Neurosci 17:2605-2614.
30. Shaham Y, Erb S, Leung S, Buczek Y, Stewart J (1998) CP-154, 526, a selective, non peptide antagonist of the corticotropin-releasing factor type 1 receptor attenuates stress-induced relapse to drug seeking in cocaine-and heroin-trained rats. Psychopharmacology 137:184-190.
31. Shaham Y, Erb S, Stewart J (2000) Stress-induced relapse to heroin and cocaine seeking in rats: A review. Brain Res Rev 33:13-33.
32. Shalev U, Grimm JW, Shaham Y (2002) Neurobiology of relapse to heroin and cocaine: A review. Pharmacol Rev 54:1-42.
33. Sinha R (2001) How does stress increase risk of drug abuse and relapse. Psychopharmacology 158:343-359.
34. Stewart J, de Wit H (1987) Reinstatement of drug-taking behavior as a method of assessing incentive motivational properties of drugs. In: Methods of Assessing the Reinforcing Properties of Abused Drugs (Bozarth MA, ed), pp 211-227. New York: Springer.
35. Swanson L, Sawchenko P, Rivier J, Vale W (1983) Organization of bovine corticotropin releasing factor immunoreactive cells and fibers in the rat brain: An immunohistochemical study. Neuroendocrinology 36:165-186.
36. Tomkins DM, Sellers EM, Fletcher PJ (1994) Median and dorsal raphe injection of the 5-HT1a agonist, 8-OHDPAT, and GABAA agonist, muscimol, increase voluntary ethanol intake in Wistar rats. Neuropharmacology 33:349-358.
37. Van Pett K, Viau V, Bittencourt JC, Chan RK, Li HY, Arias C, Prins GS, Perrin M, Vale W, Sawchenko PE (2000) Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol 428:191-212.
38. Vertes RP (1991) A PHA-L analysis of ascending projections of the dorsal raphe nucleus in the rat. J Comp Neurol 313:643-668.